European Journal of Chemistry 2017, 8(4), 430-433. doi:10.5155/eurjchem.8.4.430-433.1667

Quality by design (QbD) and process analytical technology (PAT) applications in pharmaceutical industry


Selda Dogan Calhan (1,*) , Ebru Derici Eker (2) , Nefise Ozlen Sahin (3)

(1) Department of Pharmaceutical Biotechnology, Faculty of Pharmacy, Mersin University, 33169, Mersin, Turkey
(2) Department of Pharmaceutical Biotechnology, Faculty of Pharmacy, Mersin University, 33169, Mersin, Turkey
(3) Department of Pharmaceutical Biotechnology, Faculty of Pharmacy, Mersin University, 33169, Mersin, Turkey
(*) Corresponding Author

Received: 01 Nov 2017, Accepted: 14 Nov 2017, Published: 31 Dec 2017

Abstract


Quality by Design (QbD) for the pharmaceutical industry includes the design, development and production control of products and production processes from the beginning to the end of the product development phase for ensuring the consistent quality of a pharmaceutical product. The QbD is a systematic scientific approach aimed at meeting the needs of the patient in the desired and targeted quality and aiming to produce the same quality pharmaceutical product in this direction. Process Analytical Technology, which is assessed in that regard, is part of a design quality approach that is used to design, analyze, and control real-time measurements of quality and performance criteria for raw and processed materials to achieve the desired final product. This scientific and systematic approach to pharmaceutical product development, which is also acknowledged and supported by the health authorities, serves to the changing and developing pharmaceutical sector.


Keywords


Drug; Spectroscopy; Quality by design; Product development; Pharmaceutical industry; Process analytical technology

Full Text:

PDF /    /


DOI: 10.5155/eurjchem.8.4.430-433.1667

Article Metrics


This Abstract was viewed 876 times | PDF Article downloaded 221 times

Citations

/


[1]. Valentina D’Atri, Szabolcs Fekete, Adrian Clarke, Jean-Luc Veuthey, Davy Guillarme
Recent Advances in Chromatography for Pharmaceutical Analysis
Analytical Chemistry  91(1), 210, 2019
DOI: 10.1021/acs.analchem.8b05026
/


References

[1]. Mike, F.; Bozdag, P. S.; Oner, L. Hacettepe Univ. J. Fac. Pharm. 2013, 33(2), 203-230.

[2]. Turkey Pharmaceutical Sector Vision 2023 Report Strategy Document, Association of Research-Based Pharmaceutical Companies. 2012, pp. 23-27.

[3]. DeMatas, M.; DeBeer, T.; Folestad, S.; Ketolainen, J.; Linden, H.; Lopes, J. A.; Oostra, W.; Weimer, M.; Ohrngren, P.; Rantanen, J. Eur. J. Pharm. Sci. 2016, 90, 2-7.
https://doi.org/10.1016/j.ejps.2016.04.024

[4]. Raman, N. V. V. S. S.; Mallu, U. R.; Bapatu, H. R. J. Chem. 2015, 2015, 1-8, ID: 435129.

[5]. Politis, S. N.; Colombo, P.; Colombo, G.; Rekkas, D. M. Drug Dev. Ind. Pharm. 2017, 43(6), 889-901.
https://doi.org/10.1080/03639045.2017.1291672

[6]. Rantanen, J.; Khinast, J. J. Pharm. Sci. 2015, 104(11), 3612-3638.
https://doi.org/10.1002/jps.24594

[7]. Burggraeve, A.; Monteyne, T.; Vervaet, C.; Remon, J. P.; Beer, T. Eur. J. Pharm. Biopharm. 2013, 83(1), 2-15.
https://doi.org/10.1016/j.ejpb.2012.09.008

[8]. Ferreira, A. P.; Tobyn, M. Pharm. Dev. Technol. 2015, 20(5), 513-527.
https://doi.org/10.3109/10837450.2014.898656

[9]. Pramod, K.; Tahir, M. A.; Charoo, N.; Ansari, S.; Ali, H. Int. J. Pharm. Investig. 2016, 6(3), 129-138.
https://doi.org/10.4103/2230-973X.187350

[10]. Rathore, A. S.; Bhambure, R.; Ghare, V. Anal. Bioanal. Chem. 2010, 398(1), 137-154.
https://doi.org/10.1007/s00216-010-3781-x

[11]. Haleem, R. M.; Salem, M. Y.; Fatahallah, F. A.; Abdelfattah, L. E. Saudi Pharm. J. 2015, 23(5), 463-469.
https://doi.org/10.1016/j.jsps.2013.11.004

[12]. Aksu, B.; Beer, T.; Folestad, S.; Ketolainen, J.; Linden, H.; Lopes, J. A.; Matas, M.; Oostra, W.; Rantanen, J.; Weimer, M. Eur. J. Pharm. Sci. 2012, 47(2), 402-405.
https://doi.org/10.1016/j.ejps.2012.06.009

[13]. FDA, Guidance for Industry PAT - A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance, 2004.

[14]. Zhang, L.; Mao, S. Asian J. Pharm. Sci. (AJPS) 2017, 12(1), 1-8.

[15]. Peres, D. D.; Ariede, M. B.; Candido, T. M.; Almeida, T. S.; Lourenco, F. R.; Consiglieri, V. O.; Kaneko, T. M.; Velasco, M. V. R.; Baby, A. R. Drug Dev. Ind. Pharm. 2017, 43(2), 246-256.
https://doi.org/10.1080/03639045.2016.1236809

[16]. Naidu, V. R.; Deshpande, R. S.; Syed, M. R.; Deoghare, P.; Singh, D.; Wakte, P. S. AAPS Pharm. Sci. Tech. 2017, 18(6), 2045-2054.
https://doi.org/10.1208/s12249-016-0680-2

[17]. Hertrampf, A.; Muller, H.; Menezes, J. C.; Herdling, T. J. Pharm. Biomed. Anal. 2015, 114, 208-215.
https://doi.org/10.1016/j.jpba.2015.05.012

[18]. Chavez, P. F.; Lebrun, P.; Sacre, P. Y.; Bleye, C.; Netchacovitch, L.; Cuypers, S.; Mantanus, J.; Motte, H.; Schubert, M.; Evrard, B.; Hubert, P.; Ziemons, E. Int. J. Pharm. 2015, 486, 13-20.
https://doi.org/10.1016/j.ijpharm.2015.03.025

[19]. Warnecke, S.; Rinnan, A.; Alleso, M.; Engelsen, S. B. Appl. Spectrosc. 2015, 69(3), 323-331.
https://doi.org/10.1366/14-07470

[20]. Yan, B.; Chen, T.; Xu, Z.; Qu, H. J. Pharm. Biomed. Anal. 2014, 94, 116-110.
https://doi.org/10.1016/j.jpba.2014.01.033

[21]. Jin, Y.; Wu, Z.; Liu, X.; Wu, Y. J. Pharm. Biomed. Anal. 2013, 77, 32-39.
https://doi.org/10.1016/j.jpba.2013.01.012

[22]. Simone, E.; Zhang, W.; Nagy, Z. K. J. Chem. Technol. Biotechnol. 2016, 91, 1461-1470.
https://doi.org/10.1002/jctb.4743

[23]. Kim, D. W.; Park, J. B.; Lee, S. H.; Weon, K. Y. J. Drug Delivery Sci. Technol. 2017, 39, 8-15.
https://doi.org/10.1016/j.jddst.2017.02.008

[24]. Rosas, J. G.; Blanco, M.; Gonzalez, J. M.; Alcala, M. Talanta 2012, 97, 163-170.
https://doi.org/10.1016/j.talanta.2012.04.012

[25]. Wu, Y.; Jin, Y.; Li, Y.; Sun, D.; Liu, X.; Chen, Y. Vib. Spectrosc. 2012, 58, 109-118.
https://doi.org/10.1016/j.vibspec.2011.10.006


How to cite


Calhan, S.; Eker, E.; Sahin, N. Eur. J. Chem. 2017, 8(4), 430-433. doi:10.5155/eurjchem.8.4.430-433.1667
Calhan, S.; Eker, E.; Sahin, N. Quality by design (QbD) and process analytical technology (PAT) applications in pharmaceutical industry. Eur. J. Chem. 2017, 8(4), 430-433. doi:10.5155/eurjchem.8.4.430-433.1667
Calhan, S., Eker, E., & Sahin, N. (2017). Quality by design (QbD) and process analytical technology (PAT) applications in pharmaceutical industry. European Journal of Chemistry, 8(4), 430-433. doi:10.5155/eurjchem.8.4.430-433.1667
Calhan, Selda, Ebru Derici Eker, & Nefise Ozlen Sahin. "Quality by design (QbD) and process analytical technology (PAT) applications in pharmaceutical industry." European Journal of Chemistry [Online], 8.4 (2017): 430-433. Web. 23 Oct. 2019
Calhan, Selda, Eker, Ebru, AND Sahin, Nefise. "Quality by design (QbD) and process analytical technology (PAT) applications in pharmaceutical industry" European Journal of Chemistry [Online], Volume 8 Number 4 (31 December 2017)

DOI Link: https://doi.org/10.5155/eurjchem.8.4.430-433.1667

Refbacks

  • There are currently no refbacks.




Copyright (c)




© Copyright 2019  Atlanta Publishing House LLC All Right Reserved.

The opinions expressed in all articles published in European Journal of Chemistry are those of the specific author(s), and do not necessarily reflect the views of Atlanta Publishing House LLC, or European Journal of Chemistry, or any of its employees.

Copyright 2019 Atlanta Publishing House LLC. All rights reserved. This site is owned and operated by Atlanta Publishing House LLC whose registered office is 4614 Lavista road, Tucker, GA, 30084, USA. Registered in USA.